Rossari Cash And Short Term Investments vs Current Deferred Revenue Analysis

ROSSARI Stock

831.90 6.45 0.78%

Rossari Biotech financial indicator trend analysis is much more than just breaking down Rossari Biotech prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rossari Biotech is a good investment. Please check the relationship between Rossari Biotech Cash And Short Term Investments and its Current Deferred Revenue accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Cash And Short Term Investments vs Current Deferred Revenue

Cash And Short Term Investments vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Rossari Biotech Cash And Short Term Investments account and Current Deferred Revenue. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Rossari Biotech's Cash And Short Term Investments and Current Deferred Revenue is 0.44. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Rossari Biotech Limited, assuming nothing else is changed. The correlation between historical values of Rossari Biotech's Cash And Short Term Investments and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Rossari Biotech Limited are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Cash And Short Term Investments i.e., Rossari Biotech's Cash And Short Term Investments and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.44

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Rossari Biotech balance sheet. This account contains Rossari Biotech investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Rossari Biotech Limited fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from Rossari Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rossari Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current Tax Provision is estimated to decrease to about 316.8 M. The current Selling General Administrative is estimated to decrease to about 107.3 M

	2022	2023	2024	2025 (projected)
Interest Expense	223.2M	193.7M	222.8M	233.9M
Depreciation And Amortization	629.3M	603.9M	694.5M	729.2M

Interest Expense Depreciation And Amortization

Rossari Biotech fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets
Total Assets		0.83	0.93	1.0	1.0	0.97	0.97	1.0	0.54	0.58	0.99	0.91	0.75	1.0	0.59	0.64	0.65	0.86	0.79	0.54	0.93	0.99	0.93	0.91	1.0	1.0
Short Long Term Debt Total	0.83		0.93	0.87	0.83	0.77	0.73	0.82	0.13	0.91	0.87	0.66	0.49	0.8	0.5	0.53	0.51	0.78	0.54	0.47	0.65	0.86	0.95	0.79	0.83	0.85
Other Current Liab	0.93	0.93		0.95	0.93	0.89	0.85	0.92	0.39	0.75	0.95	0.79	0.63	0.91	0.46	0.51	0.54	0.78	0.67	0.45	0.75	0.94	1.0	0.84	0.92	0.93
Total Current Liabilities	1.0	0.87	0.95		0.99	0.96	0.95	0.99	0.48	0.65	1.0	0.89	0.71	0.99	0.58	0.64	0.62	0.87	0.78	0.51	0.9	0.99	0.95	0.91	0.99	1.0
Total Stockholder Equity	1.0	0.83	0.93	0.99		0.97	0.98	1.0	0.54	0.58	0.99	0.91	0.75	0.99	0.59	0.63	0.65	0.85	0.79	0.55	0.92	0.99	0.93	0.9	0.99	1.0
Other Liab	0.97	0.77	0.89	0.96	0.97		0.93	0.97	0.66	0.52	0.94	0.87	0.75	0.99	0.53	0.56	0.56	0.8	0.72	0.4	0.96	0.96	0.89	0.96	0.98	0.96
Net Tangible Assets	0.97	0.73	0.85	0.95	0.98	0.93		0.97	0.57	0.44	0.96	0.93	0.8	0.96	0.67	0.69	0.76	0.8	0.85	0.66	0.91	0.95	0.84	0.82	0.96	0.98
Property Plant And Equipment Net	1.0	0.82	0.92	0.99	1.0	0.97	0.97		0.52	0.59	0.99	0.9	0.7	1.0	0.55	0.61	0.61	0.89	0.79	0.5	0.92	0.99	0.92	0.9	0.99	0.99
Current Deferred Revenue	0.54	0.13	0.39	0.48	0.54	0.66	0.57	0.52		-0.22	0.45	0.52	0.78	0.59	0.33	0.22	0.44	0.15	0.41	0.22	0.7	0.45	0.37	0.59	0.55	0.5
Net Debt	0.58	0.91	0.75	0.65	0.58	0.52	0.44	0.59	-0.22		0.65	0.38	0.08	0.56	0.2	0.27	0.15	0.72	0.26	0.17	0.37	0.66	0.79	0.58	0.59	0.61
Retained Earnings	0.99	0.87	0.95	1.0	0.99	0.94	0.96	0.99	0.45	0.65		0.9	0.69	0.98	0.56	0.62	0.63	0.87	0.79	0.54	0.87	0.99	0.95	0.87	0.98	1.0
Accounts Payable	0.91	0.66	0.79	0.89	0.91	0.87	0.93	0.9	0.52	0.38	0.9		0.76	0.9	0.62	0.73	0.69	0.75	0.88	0.59	0.85	0.88	0.78	0.77	0.9	0.91
Cash	0.75	0.49	0.63	0.71	0.75	0.75	0.8	0.7	0.78	0.08	0.69	0.76		0.75	0.79	0.72	0.88	0.32	0.71	0.74	0.79	0.65	0.6	0.72	0.74	0.74
Non Current Assets Total	1.0	0.8	0.91	0.99	0.99	0.99	0.96	1.0	0.59	0.56	0.98	0.9	0.75		0.56	0.61	0.61	0.85	0.77	0.49	0.94	0.98	0.91	0.92	1.0	0.99
Non Currrent Assets Other	0.59	0.5	0.46	0.58	0.59	0.53	0.67	0.55	0.33	0.2	0.56	0.62	0.79	0.56		0.91	0.9	0.33	0.76	0.88	0.62	0.51	0.46	0.57	0.6	0.62
Other Assets	0.64	0.53	0.51	0.64	0.63	0.56	0.69	0.61	0.22	0.27	0.62	0.73	0.72	0.61	0.91		0.82	0.48	0.78	0.8	0.65	0.58	0.5	0.6	0.65	0.66
Cash And Short Term Investments	0.65	0.51	0.54	0.62	0.65	0.56	0.76	0.61	0.44	0.15	0.63	0.69	0.88	0.61	0.9	0.82		0.31	0.74	0.97	0.61	0.56	0.52	0.51	0.63	0.67
Net Receivables	0.86	0.78	0.78	0.87	0.85	0.8	0.8	0.89	0.15	0.72	0.87	0.75	0.32	0.85	0.33	0.48	0.31		0.64	0.28	0.75	0.91	0.81	0.74	0.86	0.86
Common Stock Shares Outstanding	0.79	0.54	0.67	0.78	0.79	0.72	0.85	0.79	0.41	0.26	0.79	0.88	0.71	0.77	0.76	0.78	0.74	0.64		0.69	0.72	0.77	0.65	0.62	0.78	0.81
Short Term Investments	0.54	0.47	0.45	0.51	0.55	0.4	0.66	0.5	0.22	0.17	0.54	0.59	0.74	0.49	0.88	0.8	0.97	0.28	0.69		0.46	0.46	0.43	0.35	0.51	0.58
Non Current Liabilities Total	0.93	0.65	0.75	0.9	0.92	0.96	0.91	0.92	0.7	0.37	0.87	0.85	0.79	0.94	0.62	0.65	0.61	0.75	0.72	0.46		0.88	0.76	0.94	0.94	0.9
Inventory	0.99	0.86	0.94	0.99	0.99	0.96	0.95	0.99	0.45	0.66	0.99	0.88	0.65	0.98	0.51	0.58	0.56	0.91	0.77	0.46	0.88		0.95	0.89	0.99	0.99
Other Current Assets	0.93	0.95	1.0	0.95	0.93	0.89	0.84	0.92	0.37	0.79	0.95	0.78	0.6	0.91	0.46	0.5	0.52	0.81	0.65	0.43	0.76	0.95		0.86	0.92	0.94
Other Stockholder Equity	0.91	0.79	0.84	0.91	0.9	0.96	0.82	0.9	0.59	0.58	0.87	0.77	0.72	0.92	0.57	0.6	0.51	0.74	0.62	0.35	0.94	0.89	0.86		0.93	0.89
Total Liab	1.0	0.83	0.92	0.99	0.99	0.98	0.96	0.99	0.55	0.59	0.98	0.9	0.74	1.0	0.6	0.65	0.63	0.86	0.78	0.51	0.94	0.99	0.92	0.93		0.99
Total Current Assets	1.0	0.85	0.93	1.0	1.0	0.96	0.98	0.99	0.5	0.61	1.0	0.91	0.74	0.99	0.62	0.66	0.67	0.86	0.81	0.58	0.9	0.99	0.94	0.89	0.99

Click cells to compare fundamentals

Rossari Biotech Account Relationship Matchups

High Positive Relationship

Total Current Liabilities	+ 1.0	Total Assets
Total Stockholder Equity	+ 1.0	Total Assets
Property Plant And Equipment Net	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets

High Negative Relationship

Net Debt

- 0.22

Current Deferred Revenue

Rossari Biotech fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	5.6B	12.6B	13.7B	15.7B	18.1B	19.0B
Other Current Liab	190.7M	157.1M	1.1B	1.3B	1.5B	1.6B
Total Current Liabilities	1.5B	2.9B	3.5B	4.2B	4.9B	5.1B
Total Stockholder Equity	4.1B	8.1B	9.2B	10.5B	12.0B	12.7B
Other Liab	35.6M	21.7M	23.9M	1.6B	1.8B	1.9B
Net Tangible Assets	1.2B	2.8B	4.0B	5.4B	6.3B	6.6B
Property Plant And Equipment Net	1.7B	3.5B	3.3B	4.3B	4.9B	5.1B
Current Deferred Revenue	53.9M	903.5M	1.2B	125.1M	143.9M	261.6M
Net Debt	(152.1M)	(290.5M)	41.0M	936.2M	1.1B	1.1B
Retained Earnings	2.4B	3.3B	4.4B	5.6B	6.5B	6.8B
Accounts Payable	1.3B	1.9B	1.8B	2.2B	2.5B	1.4B
Cash	152.1M	374.8M	698.3M	251.7M	289.5M	254.9M
Non Current Assets Total	2.1B	6.5B	6.5B	7.3B	8.4B	8.8B
Non Currrent Assets Other	55.9M	130.5M	183.4M	104.4M	120.0M	122.5M
Other Assets	130.3M	255.6M	58.9M	144.0M	165.6M	114.4M
Cash And Short Term Investments	883.6M	644.3M	1.5B	667.9M	768.0M	732.6M
Net Receivables	1.5B	3.0B	(23.4M)	4.3B	4.9B	5.1B
Common Stock Shares Outstanding	51.9M	55.2M	55.4M	55.3M	63.6M	53.1M
Short Term Investments	731.5M	269.5M	819.5M	416.2M	478.6M	477.7M
Liabilities And Stockholders Equity	5.6B	12.6B	13.7B	15.7B	18.1B	19.0B
Non Current Liabilities Total	23.9M	1.6B	1.1B	996.9M	1.1B	1.2B
Inventory	953.5M	1.9B	1.9B	2.8B	3.2B	3.4B
Other Current Assets	242.2M	500.8M	3.8B	4.9B	5.7B	6.0B
Other Stockholder Equity	(2.5B)	4.6B	4.6B	4.7B	5.4B	5.7B
Total Liab	1.5B	4.5B	4.5B	5.2B	6.0B	6.3B
Total Current Assets	3.5B	6.1B	7.2B	8.4B	9.7B	10.2B
Short Term Debt	53.9M	(714.9M)	390.0M	745.6M	857.5M	900.3M
Intangible Assets	107.6M	1.7B	1.5B	1.4B	1.7B	1.7B
Common Stock	103.9M	110.1M	110.3M	110.5M	127.1M	91.9M
Property Plant Equipment	708.6M	1.1B	1.7B	3.5B	4.0B	4.2B
Net Invested Capital	4.1B	8.1B	9.9B	11.5B	13.3B	13.9B
Short Long Term Debt	0.0	84.3M	390.0M	725.0M	833.8M	875.5M
Net Working Capital	2.0B	3.1B	3.7B	4.2B	4.8B	2.5B
Capital Stock	103.9M	110.1M	110.3M	110.5M	127.1M	106.4M
Property Plant And Equipment Gross	2.2B	4.3B	3.3B	3.6B	4.2B	3.2B
Accumulated Other Comprehensive Income	21.2M	32.9M	35.0M	35.4M	40.7M	28.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

Other Information on Investing in Rossari Stock

Balance Sheet is a snapshot of the financial position of Rossari Biotech at a specified time, usually calculated after every quarter, six months, or one year. Rossari Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Rossari Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Rossari currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Rossari Cash And Short Term Investments vs Current Deferred Revenue Analysis

Cash And Short Term Investments vs Current Deferred Revenue

Cash And Short Term Investments vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Cash And Short Term Investments

Current Deferred Revenue

Rossari Biotech fundamental ratios Correlations

Rossari Biotech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Rossari Biotech fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Rossari Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY